全文获取类型
收费全文 | 6663篇 |
免费 | 556篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 221篇 |
妇产科学 | 236篇 |
基础医学 | 843篇 |
口腔科学 | 92篇 |
临床医学 | 611篇 |
内科学 | 1734篇 |
皮肤病学 | 157篇 |
神经病学 | 776篇 |
特种医学 | 216篇 |
外国民族医学 | 4篇 |
外科学 | 694篇 |
综合类 | 21篇 |
一般理论 | 3篇 |
预防医学 | 356篇 |
眼科学 | 61篇 |
药学 | 480篇 |
中国医学 | 11篇 |
肿瘤学 | 716篇 |
出版年
2024年 | 14篇 |
2023年 | 135篇 |
2022年 | 128篇 |
2021年 | 465篇 |
2020年 | 267篇 |
2019年 | 294篇 |
2018年 | 360篇 |
2017年 | 217篇 |
2016年 | 254篇 |
2015年 | 297篇 |
2014年 | 314篇 |
2013年 | 393篇 |
2012年 | 521篇 |
2011年 | 457篇 |
2010年 | 226篇 |
2009年 | 197篇 |
2008年 | 332篇 |
2007年 | 328篇 |
2006年 | 307篇 |
2005年 | 263篇 |
2004年 | 254篇 |
2003年 | 235篇 |
2002年 | 175篇 |
2001年 | 75篇 |
2000年 | 54篇 |
1999年 | 72篇 |
1998年 | 43篇 |
1997年 | 28篇 |
1996年 | 27篇 |
1995年 | 28篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 46篇 |
1991年 | 38篇 |
1990年 | 44篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 32篇 |
1986年 | 32篇 |
1985年 | 19篇 |
1984年 | 25篇 |
1983年 | 14篇 |
1982年 | 11篇 |
1979年 | 12篇 |
1974年 | 11篇 |
1971年 | 11篇 |
1970年 | 21篇 |
1969年 | 16篇 |
1968年 | 11篇 |
1967年 | 10篇 |
排序方式: 共有7278条查询结果,搜索用时 31 毫秒
91.
Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. 总被引:1,自引:0,他引:1
E C van Dalen H J H van der Pal C van den Bos H N Caron L C M Kremer 《Journal of clinical oncology》2003,21(17):3377; author reply 3377-3377; author reply 3378
92.
Lauren E Abrey Craig H Moskowitz Warren P Mason Michael Crump Douglas Stewart Peter Forsyth Nina Paleologos Denise D Correa Nicole D Anderson Dawn Caron Andrew Zelenetz Stephen D Nimer Lisa M DeAngelis 《Journal of clinical oncology》2003,21(22):4151-4156
PURPOSE: To assess the safety and efficacy of intensive methotrexate-based chemotherapy followed by high-dose chemotherapy (HDT) with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma (PCNSL). PATIENTS AND METHODS: Twenty-eight patients received induction chemotherapy using high-dose systemic methotrexate (3.5 g/m2) and cytarabine (3 g/m2 daily for 2 days). Fourteen patients with chemosensitive disease evident on neuroimaging then received high-dose therapy using carmustine, etoposide, cytarabine, and melphalan with autologous stem-cell rescue. RESULTS: The objective response rate to the induction-phase chemotherapy was 57%, and median overall survival is not yet assessable, with a median follow-up time of 28 months. The overall median event-free survival time is 5.6 months for all patients and 9.3 months for 14 patients who underwent transplantation. Six of these 14 patients (43%) remained disease-free at last follow-up. Treatment was well tolerated; there was one transplantation-related death. Prospective neuropsychologic evaluations have revealed no evidence of treatment-related neurotoxicity. CONCLUSION: This treatment approach is feasible in patients with newly diagnosed PCNSL without evidence of significant related neurotoxicity. Although the transplantation results are similar to those achieved in patients with aggressive or poor-prognosis systemic lymphoma, the low response rate to induction chemotherapy and the significant number of patients who experienced relapse soon after HDT suggest that more aggressive induction chemotherapy may be warranted. 相似文献
93.
Dellovade TL Young M Ross EP Henderson R Caron K Parker K Tobet SA 《The Journal of comparative neurology》2000,423(4):579-589
The ventromedial nucleus of the hypothalamus (VMH) in mice first emerges as a histologically distinct cell cluster around embryonic day 17 (E17). The earliest known marker for cells destined to form the VMH is the orphan nuclear receptor, steroidogenic factor 1 (SF-1), which can be detected in the hypothalamic primordium by E11. Strikingly, the VMH is absent in newborn SF-1 knockout mice, suggesting that SF-1 is essential for the development of VMH neurons. We reported previously that the VMH can be identified before it emerges as a histologically distinct nucleus (i.e., at E13) by the exclusion of cells that are immunoreactive for both gamma-aminobutyric acid (GABA) and the synthetic enzyme, glutamic acid decarboxylase (GAD67). Subsequently, by E15, the developing VMH is demarcated further by cells that are immunoreactive for neuropeptide Y, estrogen receptor alpha (ERalpha), and galanin. It is noteworthy that the normal exclusion of GABA from the developing VMH is not seen in SF-1 knockout mice, and cells that are immunoreactive for neuropeptide Y, ERalpha, and galanin also are distributed aberrantly in this region. Thus, the absence of SF-1 profoundly affects the cellular architecture of the VMH from early stages in its formation. These data suggest that, directly or indirectly, SF-1 plays important roles in determining the distribution of cells in the mediobasal hypothalamus. 相似文献
94.
Parent and physician perspectives on quality of care at the end of life in children with cancer. 总被引:1,自引:0,他引:1
Jennifer W Mack Joanne M Hilden Jan Watterson Caron Moore Brian Turner Holcombe E Grier Jane C Weeks Joanne Wolfe 《Journal of clinical oncology》2005,23(36):9155-9161
PURPOSE: To ascertain parents' and physicians' assessments of quality of end-of-life care for children with cancer and to determine factors associated with high-quality care as perceived by parents and physicians. METHODS: A survey was conducted between 1997 and 2001 of 144 parents of children who received treatment at the Dana-Farber Cancer Institute and Children's Hospital (Boston, MA) or Children's Hospitals and Clinics of St Paul and Minneapolis, MN, between 1990 and 1999 (65% of those located and eligible) and 52 pediatric oncologists. RESULTS: In multivariable models, higher parent ratings of physician care were associated with physicians giving clear information about what to expect in the end-of-life period (odds ratio [OR] = 19.90, P = .02), communicating with care and sensitivity (OR = 7.67, P < .01), communicating directly with the child when appropriate (OR = 11.18, P < .01), and preparing the parent for circumstances surrounding the child's death (OR = 4.84, P = .03). Parent reports of the child's pain and suffering were not significant correlates of parental ratings of care (P = .93 and .35, respectively). Oncologists' ratings of care were inversely associated with the parent's report of the child's experience of pain (OR = 0.15, P = .01) and more than 10 hospital days in the last month of life (OR = 0.24, P < .01). Parent-rated communication factors were not correlates of oncologist-rated care. No association was found between parent and physician care ratings (P = .88). CONCLUSION: For parents of children who die of cancer, doctor-patient communication is the principal determinant of high-quality physician care. In contrast, physicians' care ratings depend on biomedical rather than relational aspects of care. 相似文献
95.
Alasdair M Barr Virginia Lehmann-Masten Martin Paulus Raul R Gainetdinov Marc G Caron Mark A Geyer 《Neuropsychopharmacology》2004,29(2):221-228
A hyperdopaminergic state in humans has been hypothesized to contribute to the pathology of a number of psychiatric illnesses, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. Mice that display elevated synaptic levels of dopamine due to a genetically engineered deletion of the dopamine transporter (DAT) model behavioral deficits that simulate the above conditions. As novel treatment strategies for these disorders have focused on the serotonin (5-HT) 2A receptor, we determined the capacity of the highly selective 5-HT(2A) receptor antagonist M100907 to reverse behavioral deficits in DAT knockout (KO) mice. Prior to drug treatment, DAT KO mice exhibited increased levels of locomotor activity and highly linearized movement in a novel environment, as well as reduced prepulse inhibition (PPI) of acoustic startle, compared to wild-type littermates. Treatment with M100907 (0.3-1.0 mg/kg, but not 0.1 mg/kg) reversed locomotor deficits in DAT KO mice. Similarly, treatment with 1.0 mg/kg M100907 reversed the PPI deficits in DAT KO mice. These data indicate that selective 5-HT(2A) receptor antagonists, such as M100907, may represent a class of drugs that can be used to treat conditions in which a chronic, elevated dopaminergic tone is present and contributes to abnormal behavior and sensorimotor gating deficits. 相似文献
96.
97.
98.
Matteo Lazzaretti Dora Fabbro Michela Sala Kether Del Toso Giulia de Vidovich Elisa Marraffini 《Behavioral medicine (Washington, D.C.)》2013,39(2):25-28
The objective of the present study was to test the association between Borderline Personality Disorder (BPD) and the cathecolamine-O-methyl-transferase (COMT) low-activity (Met158) single nucleotide polymorphism (SNP). In this case-control study, DNA was obtained from venous blood of 19 BPD patients and 36 healthy subjects. COMT-Val158Met single-nucleotide polymorphism was genotyped by predesigned SNP assay. The COMT Met158 allele was over-represented in patients with BPD in comparison to normal subjects (68.4% vs 44.4%, respectively; Fisher exact test, p = .02). In terms of genotype, the Met158Met subjects were more frequent in patients versus controls (47.4% vs 22.2%, respectively), whereas the high-activity genotype Val158Val was under-represented (10.5% vs 33.3%, respectively). The allele encoding for the COMT with low enzymatic efficiency was found to be over-represented in BPD, possibly resulting in excessive synaptic dopaminergic activity and ultimately affecting externalizing behaviours, such as impulsivity and aggressiveness. 相似文献
99.
Fabio Salvatore Macaluso Marco Ventimiglia Walter Fries Anna Viola Aldo Sitibondo Maria Cappello Barbara Scrivo Anita Busacca Antonino Carlo Privitera Salvatore Camilleri Serena Garufi Roberto Di Mitri Filippo Mocciaro Nunzio Belluardo Emiliano Giangreco Carmelo Bertolami Sara Renna Rosalba Orlando Giulia Rizzuto Mario Cottone Ambrogio Orlando 《Journal of gastroenterology and hepatology》2021,36(1):105-111
100.
In vitro development of engineered muscle using a scaffold based on the pressure‐activated microsyringe (PAM) technique 下载免费PDF全文
Daniele Cei Adriana Malena Carmelo de Maria Emanuele Loro Federica Sandri Giulia del Moro Sara Bettio Lodovica Vergani Giovanni Vozzi 《Journal of tissue engineering and regenerative medicine》2017,11(1):138-152
The development of new human skeletal muscle tissue is an alternative approach to the replacement of tissue after severe damage, for example in the case of traumatic injury, where surgical reconstruction is often needed following major loss of natural tissue. Treatment to date has involved the transfer of muscle tissue from other sites, resulting in a functional loss and volume deficiency of donor sites. Approaches that seek to eliminate these problems include the relatively new solution of skeletal muscle engineering. Here there are two main components to consider: (a) the cells with their regenerative potential; and (b) the polymeric structure onto which cells are seeded and where they must perform their activities. In this paper we describe well‐defined two‐ and three‐dimensional polymeric structures able to drive the myoblast process of adhesion, proliferation and differentiation. We examine a series of polymers and protein adhesions with which to functionalize the structures, and cell‐seeding methods, with a view to defining the optimal protocol for engineering skeletal muscle tissue. All polymer samples were tested for their mechanical and biological properties, to support the validity of our results in the real context of muscle tissue engineering. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献